F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
WEB1 day ago · Sept. 20, 2024. The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin ...
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB1 day ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
Lawmakers unveil PBM reform bill amid rising drug costs
WEBJul 23, 2024 · The new bill joins dozens of other bipartisan efforts on the federal and state level to reform PBMs, which negotiate rebates with drug manufacturers on behalf of insurers, large employers and ...
Why PBMs, or pharmacy benefit managers, are the focus of new ... - NPR
WEBJul 7, 2023 · At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.
FTC sues insulin middlemen, saying they pocket billions while …
WEB15 hours ago · The three PBMs named in the FTC lawsuit make up about 80% of the market. According to the suit, the PBMs collected billions of dollars in rebates and fees while insulin became increasingly unaffordable. Over the last two decades, the cost of the lifesaving drug shot up 600% — forcing many Americans with diabetes to ration their medication and ...
How FTC's Battle With PBMs Could Reshape The Pharmaceutical ... - Forbes
WEBJul 20, 2024 · The FTC’s investigation of PBMs marks a pivotal moment in the ongoing effort to reform the healthcare industry and ensure that it serves the best interests of patients.
Pharmacy benefit managers profit at expense of patients and small ... - CNN
WEBJul 9, 2024 · Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent...
How PBMs Are Driving Up Prescription Drug Costs - The New York Times
WEBJun 21, 2024 · The three largest pharmacy benefit managers, or P.B.M.s, act as middlemen overseeing prescriptions for more than 200 million Americans.
High insulin prices spur a federal lawsuit ... - Associated Press News
WEB1 day ago · The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have engaged in anticompetitive practices that ...
House lawmakers slam pharmacy middlemen over sky-high drug …
WEBJul 23, 2024 · The House Committee on Oversight and Accountability heard testimony from the leaders of three pharmacy benefit managers, or PBMs, one month after the Federal Trade Commission released a scathing...
- Some results have been removed
Skip to content